SuperScript IV Reverse Transcriptase, 4 x 10,000 Units and 3 more items
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0445950
- Awardee
- LIFE TECHNOLOGIES CORPORATION
- Contracting organization
- University of Virginia
- Cumulative value
- $7,978
About this award
Life Technologies Corporation was awarded contract A207_PO-0445950 by the University of Virginia on July 11, 2026, with a cumulative contract value of $7,978.41. The contract encompasses the procurement of molecular biology reagents and enzymes essential for nucleic acid research and analysis applications.
The contract specifies four line items for delivery to the University of Virginia buyer: 5,404 units of SuperScript IV Reverse Transcriptase (4 x 10,000 Units), 812 units of Random Hexamers (50 uM), 377 units of deoxyribonucleotide triphosphate Mix (10 mM each, 1 mL), and 1,384 units of RNaseOUT Recombinant Ribonuclease Inhibitor. These biochemical products are commonly utilized in reverse transcription and complementary DNA synthesis workflows for research purposes. All items are designated for delivery to the buyer with unit pricing established at $1 per item across all line items.
Line items
| Item | Total |
|---|---|
| SuperScript IV Reverse Transcriptase, 4 x 10,000 Units | $5,404.00 |
| Random Hexamers (50 uM) | $812.00 |
| dNTP Mix (10 mM ea), 1 mL | $377.00 |
| RNaseOUT Recombinant Ribonuclease Inhibitor | $1,384.00 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0445950?
Contract A207_PO-0445950 was awarded to LIFE TECHNOLOGIES CORPORATION by University of Virginia on July 11, 2026.
How much is contract A207_PO-0445950 worth?
Its cumulative value is $7,978.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award